ARCHIVES

FDA’s Young Still Not Satisfied With Distribution Plan

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

Amgen, J&J Defend ESA Indications.

March 21, 2008

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

New Grants Awarded In Tobacco Research

February 17, 1978